Sign Up Today and Learn More About Valitor Stock
Invest in or calculate the value of your shares in Valitor or other pre-IPO companies through EquityZen's platform.
Valitor Stock (VALT)
Valitor has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacological properties..
About Valitor Stock
Founded
2010
Headquarters
Berkeley, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Valitor Press Mentions
Stay in the know about the latest news on Valitor
Valitor Announces Upcoming Presentation at the 15th Annual Ophthalmology Innovation Summit (OIS)
globenewswire • Nov 20, 2025
Valitor Presents Preclinical Data Demonstrating VLTR-559 Achieves Superior Durability and Sustained Anti-VEGF Activity with a Favorable Safety Profile as a Treatment for Wet AMD
globenewswire • Oct 20, 2025
Valitor Appoints Biotech and Ophthalmic Industry Veteran Gregory D. Kunst as Chief Executive Officer
globenewswire • Oct 17, 2025
Valitor Announces Upcoming Presentation at the Eyecelerator Conference Hosted in Conjunction with the American Academy of Ophthalmology (AAO) 2025 Annual Meeting
biospace • Oct 07, 2025
Valitor Announces Upcoming Presentation at the Eyecelerator Conference Hosted in Conjunction with the American Academy of Ophthalmology (AAO) 2025 Annual Meeting
globenewswire • Oct 06, 2025
Valitor Management
Leadership team at Valitor
Board Member
Kevin Healy
Member of the Board of Directors
Walter H. Moos
Join now and verify your accreditation status to gain access to:
- Valitor Current Valuation
- Valitor Stock Price
- Valitor Management
- Available deals in Valitor and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Valitor Cap Table and Funding History by Share Class and Liquidity Preferences
- Valitor Revenue and Financials
- Valitor Highlights
- Valitor Business Model
- Valitor Risk Factors
- Valitor Research Report from SACRA Research
Trading Valitor Stock
How to invest in Valitor stock?
Accredited investors can buy pre-IPO stock in companies like Valitor through EquityZen funds. These investments are made available by existing Valitor shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Valitor stock?
Shareholders can sell their Valitor stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 51K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
